Can PCOS Cause PMDD? The Link Between the Conditions

PCOS does not directly cause PMDD, but it substantially raises the risk. A large nationwide study in Sweden found that people with polycystic ovary syndrome developed premenstrual disorders at more than twice the rate of those without PCOS, and the association held even after accounting for factors like obesity and pre-existing psychiatric conditions. The two conditions share hormonal terrain that makes co-occurrence far from coincidental, and understanding how they overlap matters for getting the right diagnosis and treatment.

What the Numbers Actually Show

The strongest evidence connecting PCOS and premenstrual disorders comes from a Swedish register-based study that followed hundreds of thousands of people over a median of about 15 years. Among those with PCOS, the rate of premenstrual disorders was roughly 4.7 per 1,000 person-years, compared to about 1.8 per 1,000 person-years in those without PCOS. When researchers accounted only for age, the risk was more than doubled. After adjusting for demographics, socioeconomic factors, psychiatric history, and obesity, the risk dropped somewhat but remained about 54% higher than in the general population.¹

One especially telling detail: the researchers compared siblings, pairing people with PCOS against their own sisters without the diagnosis. This design helps control for shared family environment and genetics. The sibling comparison still showed a roughly 61% higher risk of premenstrual disorders for the sibling with PCOS.¹ That finding matters because it suggests the link is not just explained by things that run in families. Something about PCOS itself appears to elevate the risk.

The study also looked at whether having a psychiatric history changed the picture. The association between PCOS and premenstrual disorders remained significant regardless of whether someone had pre-existing psychiatric conditions, though the risk was somewhat higher in those without prior psychiatric diagnoses.¹ In other words, the PCOS-premenstrual disorder connection is not simply a byproduct of depression or anxiety tagging along.

How the Two Conditions Share Hormonal Ground

To understand why PCOS raises the risk of PMDD specifically, it helps to know what drives PMDD in the first place. PMDD is not caused by abnormal hormone levels. People with PMDD generally have normal amounts of progesterone and estrogen circulating through their bodies. The problem lies in how their brains respond to the normal rise and fall of those hormones across the menstrual cycle.

A key player is allopregnanolone, a substance the body makes from progesterone. Allopregnanolone normally acts as a calming agent in the brain by interacting with GABA receptors, the brain’s main inhibitory system. In people with PMDD, the brain’s GABA receptors appear to respond abnormally to the natural fluctuations of allopregnanolone that happen during each cycle. When allopregnanolone rises in the luteal phase (the two weeks before a period), instead of producing a calming effect, the response goes haywire, contributing to irritability, anxiety, and depression.²³

Here is where PCOS enters the picture. PCOS disrupts the hormonal environment in ways that could amplify this vulnerability. People with PCOS often have elevated androgens, irregular progesterone production, and altered patterns of how hormones fluctuate. Changes in allopregnanolone have been implicated not only in PMDD but also in the psychiatric symptoms commonly seen in PCOS, including depression and anxiety.⁴ Researchers are still working out the specifics, but the overlap in allopregnanolone-related pathways gives a plausible biological explanation for why these two conditions cluster together more than chance would predict.

Other Biological Threads They Share

The allopregnanolone-GABA connection is the most studied shared pathway, but it is not the only one. Several other biological systems are disrupted in both PCOS and PMDD, and each could contribute to why having one condition makes the other more likely.

Serotonin is one of those systems. Brain imaging in women with PMDD has shown that serotonin receptor activity changes differently across the menstrual cycle compared to women without the condition. In the brain’s raphe nuclei, a region central to serotonin production, women without PMDD show a shift in serotonin receptor binding from the first half to the second half of the cycle. In women with PMDD, that shift is significantly smaller, suggesting their serotonin system does not adapt properly to hormonal changes.⁵ PCOS independently alters serotonin function through insulin resistance and chronic inflammation, so having PCOS could worsen serotonergic dysfunction that feeds into PMDD symptoms.

The body’s stress response system, centered on the hypothalamic-pituitary-adrenal (HPA) axis, is another shared thread. Disruptions in this system have been identified as contributing to depressive disorders at multiple reproductive stages, including during the menstrual cycle in PMDD.⁶ PCOS is also associated with HPA axis abnormalities, partly driven by chronic inflammation and insulin resistance. The features of PCOS, including excess androgens, central obesity, inflammation, and insulin resistance, are strongly interrelated with psychological symptoms like depression and anxiety.⁷ When these metabolic stressors are already straining the brain’s ability to regulate mood, the additional hormonal fluctuations of the menstrual cycle could more easily tip someone into PMDD territory.

Why the Overlap Makes Diagnosis Harder

One of the biggest practical problems for people with both PCOS and PMDD is that the symptoms can easily be mistaken for one another, or the second condition can be missed entirely. PCOS on its own is associated with higher rates of depression, anxiety, and mood instability. If you already carry a PCOS diagnosis and you report feeling emotionally overwhelmed, a clinician might attribute everything to the PCOS and never ask whether your worst symptoms track with specific phases of your cycle.

PMDD has a very specific timing pattern: symptoms appear during the luteal phase and lift within a few days of your period starting. This cyclical on-off pattern is the defining feature. But if your periods are irregular, as they often are with PCOS, tracking that timing becomes much harder. You may not know when your luteal phase begins or ends, making it difficult to recognize the rhythmic pattern that distinguishes PMDD from other mood disorders. A daily symptom diary kept over at least two full cycles is the gold standard for diagnosis, but irregular cycles stretch those cycles out and make the tracking process longer and more frustrating.

The quality-of-life cost of getting the diagnosis wrong is real. Among women with PCOS, premenstrual symptoms tend to be severe: one study of married women with PCOS found that nearly half reported severe premenstrual symptoms, and another 43% reported moderate symptoms. About 40% of participants showed severe impairment in health-related quality of life.⁸ Dismissing those symptoms as just “part of PCOS” means missing targeted treatments that could make a substantial difference.

Diet and Lifestyle as Shared Risk Modifiers

Research comparing women with and without PCOS has found that PCOS is associated not only with worse premenstrual symptoms across physical, emotional, and behavioral dimensions, but also with poorer dietary quality. A case-control study found that lower adherence to a Mediterranean-style diet was independently associated with PCOS, alongside higher premenstrual symptom scores and poorer mental health scores.⁹ This does not prove that a better diet prevents PMDD, but it suggests that nutritional factors could be one piece of the puzzle connecting the two conditions.

Emerging research on the gut-brain axis adds another layer. Studies have begun to explore whether probiotics and micronutrient supplementation can improve psychiatric symptoms in people with PCOS, partly by influencing neurotransmitter levels.¹⁰ This line of research is still early, and no one should treat probiotics as a replacement for established PMDD treatment. But for someone managing both conditions, paying attention to overall metabolic health and diet quality is unlikely to hurt and may help at the margins.

Treatment When Both Conditions Are Present

If you have PCOS and suspect you also have PMDD, the good news is that some treatments address both conditions at once, while others target each one separately without interfering with the other.

For PMDD specifically, SSRIs remain a first-line treatment. These medications can be taken continuously or only during the luteal phase, and they work on the serotonin system disruption described earlier. The only oral contraceptive specifically approved by the FDA for PMDD treatment contains drospirenone in a 24+4 day regimen, though evidence supports other hormonal formulations as well.¹¹ Hormonal contraceptives that suppress ovulation can help both conditions by reducing the cyclical hormonal fluctuations that trigger PMDD while also managing some PCOS symptoms like acne and irregular bleeding.

Metformin, commonly prescribed for PCOS to address insulin resistance, may offer mood benefits too. In one study, women with PCOS who took metformin for three months showed a meaningful drop in depression scores, and they were about 70% less likely to have major depression compared to a group using lifestyle changes alone.¹² Another trial found that both depression and anxiety scores improved in adolescent and adult women with PCOS after 90 days of metformin, alongside improvements in insulin resistance markers.¹³ Metformin is not a PMDD treatment per se, but if insulin resistance and its downstream effects on inflammation and neurotransmitter function are contributing to your mood symptoms, addressing that metabolic piece could lower the overall burden.

Broader treatment approaches for people dealing with both conditions include cognitive-behavioral therapy and mindfulness-based interventions, which have evidence for helping with the psychological aspects of PCOS and can also be useful for managing the emotional symptoms of PMDD.¹⁴ The key is making sure your treatment plan acknowledges both diagnoses rather than folding all your symptoms into one label.

When Standard Treatments Fail

For a small subset of people, PMDD resists all standard medical treatments. SSRIs do not work, hormonal contraceptives do not work, and cycle after cycle the symptoms remain debilitating. In these cases, clinicians sometimes turn to GnRH agonists, medications that temporarily shut down ovarian function and create a kind of chemical menopause. If symptoms resolve on a GnRH agonist, that confirms the hormonal origin of the problem and opens the door to a more permanent surgical option.

A case report described a 35-year-old woman whose PMDD symptoms began at her first period and worsened over two decades, resisting multiple lines of treatment. After a trial of leuprolide acetate (a GnRH agonist) confirmed that suppressing her ovarian cycles eliminated her symptoms, she underwent a total hysterectomy with removal of both ovaries. She experienced a severe depressive episode in the immediate aftermath, but has since remained in sustained remission on an SSRI and estrogen replacement therapy.¹⁵

This is clearly a last resort, and the decision carries enormous implications for fertility, bone health, and cardiovascular risk. But for someone with both PCOS and treatment-resistant PMDD, it is worth knowing the option exists, particularly since some people with PCOS are already navigating difficult reproductive decisions. The case also highlights a broader issue: diagnostic delay. The patient in this report spent years cycling through treatments before the right diagnosis and approach were found. If you have PCOS and your mood symptoms seem disproportionately tied to your cycle, pushing for a thorough evaluation for PMDD can spare years of unnecessary suffering.

The Gut-Brain Connection in PCOS and Mood

One of the more interesting frontiers in understanding why PCOS carries so much psychiatric baggage involves the gut microbiome. People with PCOS tend to have altered gut bacteria compared to those without the condition, and those microbial differences may influence brain chemistry through what researchers call the gut-brain axis. The gut produces a surprising amount of the body’s serotonin and other neurotransmitters, and disruptions in gut microbial balance can affect how those chemical messengers function.¹⁰

No one has directly studied whether gut microbiome interventions reduce PMDD symptoms in people with PCOS. The research so far focuses on general psychiatric symptoms in PCOS populations and shows some promise for probiotics and targeted micronutrient supplementation. It is a plausible pathway, given the serotonin and inflammation connections between the two conditions, but the evidence is too early-stage to guide treatment decisions. It is worth keeping an eye on as the science matures, especially if you are someone who has found that dietary changes noticeably affect your premenstrual symptoms.